2018
DOI: 10.2807/1560-7917.es.2018.23.5.17-00284
|View full text |Cite
|
Sign up to set email alerts
|

Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016

Abstract: Respiratory syncytial virus (RSV) is considered the most common pathogen causing severe lower respiratory tract infections among infants and young children. We describe the seasonality and geographical spread of RSV infection in 15 countries of the European Union and European Economic Area. We performed a retrospective descriptive study of weekly laboratory-confirmed RSV detections between weeks 40/2010 and 20/2016, in patients investigated for influenza-like illness, acute respiratory infection or following t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

20
141
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 108 publications
(162 citation statements)
references
References 35 publications
20
141
1
Order By: Relevance
“…We lacked; however, the total number of obtained samples in the national registry data. Thus, the absolute length of the epidemic is difficult to measure in the present study as compared to other studies …”
supporting
confidence: 84%
See 3 more Smart Citations
“…We lacked; however, the total number of obtained samples in the national registry data. Thus, the absolute length of the epidemic is difficult to measure in the present study as compared to other studies …”
supporting
confidence: 84%
“…Respiratory syncytial virus (RSV) is the most frequent cause of lower respiratory tract infection in infants, with a hospitalisation rate up to 35 per 1000 children younger than 1 year . RSV causes bronchiolitis, wheezing bronchitis and bronchopneumonia demanding respiratory support.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…RSV is associated with substantial morbidity and mortality since it is the major cause of lower respiratory tract infections (LRTI) during childhood resulting in hospitalization due to the severity of infection in many cases [12]. Moreover, it causes severe respiratory tract infection in adults, especially elderly, and immunosuppressed patients [13,14]. Symptomatic supportive care and Palivizumab are currently available options to RSV disease clinical management, which reduce the symptoms and severity, decreasing hospitalization rate but not mortality [15][16][17][18].…”
Section: Introductionmentioning
confidence: 99%